Antihypertensive Drugs Quiz

Which of the following best describes the general definition of hypertension according to major management guidelines (e.g., NICE, JNC8)?

• A blood pressure (BP) reading above 120/80 mm Hg for any individual.

• The level of BP at or above which long-term antihypertensive treatment will reduce cardiovascular mortality.

• A systolic BP exceeding 130 mm Hg or a diastolic BP exceeding 85 mm Hg.

• Any BP reading requiring short-term intervention to reduce immediate risk.

What was the status of effective and tolerated antihypertensive drugs prior to 1950?

• Reserpine was a widely available and effective breakthrough drug.

• Ganglion blockers were already the standard first-line treatment.

• Hydralazine was commonly used alone due to its proven efficacy.

• Hardly any effective and tolerated antihypertensive was available.

The majority of hypertension cases are classified as essential (primary) hypertension. What does this classification imply?

• The condition is always caused by an overactive sympathetic nervous system.

• It primarily affects normotensives due to unknown factors.

• The cause of the hypertension is not known.

• It is a self-limiting disorder that resolves without treatment.

According to the JNC 8 and NICE (2011) guidelines, what is the initial recommended approach for thiazide therapy in essential hypertension, particularly in the elderly?

• Increasing the dose of diuretic beyond 25 mg/day Hydrochlorothiazide (HCZ) to achieve desired BP.

• It is contraindicated in patients with chronic kidney disease (CKD).

• Instituting 12.5-25 mg/day thiazide therapy, with or without added K+ sparing diuretic, as a first choice treatment.

• Thiazides are always ineffective if used as monotherapy.

What is the proposed mechanism by which thiazide diuretics maintain a fall in blood pressure (BP) in the long term?

• An initial, profound reduction in cardiac output (c.o.).

• A slowly developing reduction in total peripheral resistance (t.p.r.) due to a small, persisting Na+ and volume deficit.

• A direct, immediate vasodilator action due to opening of smooth muscle K+ ATP channels.

• Increased sympathetic reflexes leading to reduced vascular stiffness.

Which of the following was a notable drawback of using higher doses of thiazide diuretics (e.g., 50 mg/day HCZ/chlorthalidone) in the past?

• A significant improvement in high-density lipoprotein (HDL) cholesterol levels.

• Hyperuricaemia, leading to an increased incidence of gout.

• Decreased incidence of sudden cardiac death attributed to fewer arrhythmias.

• Reduction in the risk of osteoporosis in older women.

Under what specific circumstances are high ceiling (loop) diuretics indicated for the treatment of hypertension?

• For all uncomplicated cases of mild hypertension as a first-line option.

• They are generally preferred over thiazides for routine use in normotensives.

• Only when hypertension is complicated by chronic renal failure, coexisting refractory congestive heart failure (CHF), or when fluid-retaining potent vasodilators are used.

• As the primary agent for potentiating all other antihypertensives (except Dihydropyridines - DHPs).

When is the addition of an aldosterone antagonist recommended to a hypertension regimen according to the NICE and JNC 8 guidelines?

• When serum K+ levels are consistently above 4.5 mmol/L.

• As a standard first-line treatment for all resistant hypertension cases.

• If the target blood pressure is not attained with an ACE inhibitor/Angiotensin Receptor Blocker (ARB) + Calcium Channel Blocker (CCB) + thiazide regimen.

• Only in patients with bilateral renal artery stenosis.

Based on epidemiological studies, which patient demographic tends to show a better response to ACE inhibitors/Angiotensin Receptor Blockers (ARBs) in hypertension treatment?

• Elderly patients (aged >60 years).

• Individuals of black races.

• Younger patients (<55 years) and individuals of white races.

• Patients with severe diabetic nephropathy exclusively.

A significant advantage of Angiotensin Receptor Blockers (ARBs) over ACE inhibitors, leading to their increased use, is:

• Their ability to significantly increase kinin levels for enhanced vasodilatation.

• They are known to cause a higher incidence of angioedema.

• They do not increase kinin levels, thereby avoiding the ACE inhibitor-related cough.

• They provide identical metabolic and prognostic advantages while being less effective overall.